To test the feasibility of systematically offering Informed Choice Assistance (ICA) during the diagnostic evaluation process to at least 80% of patients facing decisions about the management of uterine fibroids.
The specific aims of this research study are:
Specific aim 1: To document the number, characteristics and decisions of patients with uterine fibroids for both those who do and do not agree to take advantage of this ICA.
Specific aim 2: To measure the effect of exposure to ICA on patient knowledge, decision quality and patient activation level as compared to patients receiving usual care in HealthPartners Medical Group (HPMG) gynecology staff clinics, and to measure similar effects comparing patients exposed to ICA at HPMG staff clinics with those at the contracted Stillwater Medical Group clinic.
Specific aim 3: To evaluate patient, staff and clinician satisfaction with and perceived barriers to ICA at clinics with different organization settings.
Preliminary analysis shows significant difference between intervention and control conditions–intervention group was more informed, satisfied, and consistent
The paper summarizing the results of the retrospective study has been published by the Journal of Women’s Health. The paper reporting on the intervention trial was resubmitted to Medical Decision Making and was recently published as well.